Lawrence Recht
Clinical Trials
- BIBW 2992 With or Without Daily Temozolomide For Recurrent Malignant Glioma Recruiting
- Phase 2 of Azixa™ (MPC-6827) for Glioblastoma Multiforme in First or Second Relapse Recruiting
- An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Completed
- Phase II/III Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) No longer recruiting
- XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors Completed
- XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema No longer recruiting
- Assessing the suitability of an imaging probe for use in clinical cell and gene therapy trials in cancer and rheumatoid arthritis No longer recruiting
- Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma Completed
Help
Trial Administration